XML 18 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF NET INCOME - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
CONSOLIDATED STATEMENTS OF NET INCOME [Abstract]      
Net patient revenues $ 389,226 $ 348,839 $ 324,293
Other revenues 24,825 7,707 7,009
Net revenues 414,051 356,546 331,302
Operating costs:      
Salaries and related costs 237,067 198,495 180,514
Rent, supplies, contract labor and other 82,096 71,868 68,046
Provision for doubtful accounts 3,672 4,040 4,170
Closure costs 599 131 211
Total operating costs 323,434 274,534 252,941
Gross Profit 90,617 82,012 78,361
Corporate office costs 35,889 32,479 31,067
Operating income 54,728 49,533 47,294
Interest and other income, net 88 93 81
Interest expense:      
Mandatorily redeemable non-controlling interests - change in redemption value (12,894) (6,169) (2,670)
Mandatorily redeemable non-controlling interests - earnings allocable (6,055) (4,057) (3,538)
Debt and other (2,111) (1,252) (1,031)
Total interest expense (21,060) (11,478) (7,239)
Income before taxes 33,756 38,148 40,136
Provision for income taxes 6,032 11,880 13,647
Net income 27,724 26,268 26,489
Less: net income attributable to non-controlling interests (5,468) (5,717) (5,874)
Net income attributable to USPH shareholders $ 22,256 $ 20,551 $ 20,615
Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 1.76 $ 1.64 $ 1.66
Shares used in computation - basic and diluted (in shares) 12,570 12,500 12,392
Dividends declared per common share (in dollars per share) $ 0.80 $ 0.68 $ 0.60